CN1067271C - Capsule for curing hepatitis B - Google Patents

Capsule for curing hepatitis B Download PDF

Info

Publication number
CN1067271C
CN1067271C CN98125078A CN98125078A CN1067271C CN 1067271 C CN1067271 C CN 1067271C CN 98125078 A CN98125078 A CN 98125078A CN 98125078 A CN98125078 A CN 98125078A CN 1067271 C CN1067271 C CN 1067271C
Authority
CN
China
Prior art keywords
radix
root
capsule
hepatitis
chinese herbal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98125078A
Other languages
Chinese (zh)
Other versions
CN1227752A (en
Inventor
曾庆湘
蒙启涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98125078A priority Critical patent/CN1067271C/en
Publication of CN1227752A publication Critical patent/CN1227752A/en
Application granted granted Critical
Publication of CN1067271C publication Critical patent/CN1067271C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a method for preparing a capsule treating hepatitis B. The Chinese herbal medicines are accurately selected according to the pathogenic factors and the pathology, and the Chinese herbal medicines comprise safflower, red peony root, radish seed, tribulus terrestris, sea-ear shell, glossy privet fruit, curcuma root, Chinese angelica body, radix paeoniae alba, licorice root, eucommia bark, whitewood, radix dipsaci, tortoise plastron, turtle shell, medlar, beard root, red sage root, eupatorium and oldenlandia. Subsequently, the Chinese herbal medicines are processed into the capsule. The method of activating blood circulation to dissipate blood stasis is used for activating the rapid regeneration of liver cells so that the hepatitis B can be rapidly cured.

Description

The capsule of treatment hepatitis B
What the present invention relates to is the capsular preparation method of a kind of treatment hepatitis B disease.
Hepatitis has polytype, and hepatitis B sickness rate height is a kind of common disease, multiple disease.Hepatitis B can develop to liver cirrhosis, and liver cirrhosis develops to hepatocarcinoma, and this sick directly prestige is doing harm to people's physical and mental health and life.Its etiology and pathology is how evil touching by damp and hot poison, with the passing of time healthy energy damage, by the real void that causes, form stagnation of liver-QI with deficiency of the spleen, deficiency of the liver and kindey, arteries and veins arm stasis of blood resistance etc., the pathological manifestations of simulataneous insufficiency and excessive, the primary disease western medicine and medical practitioners does not have special Therapeutic Method, the general hepatic that adopts, antiviral drugs, treatments such as immunomodulator, clinical observation are all not ideal enough, hepatitis B shows no sign of minimizing to fear and the worry that the mankind bring, a kind of treatment hepatitis B capsule was developed in the clinical study while putting into practice through more than 30 years, had solved the deficiency of original treatment hepatitis B.
Purpose of the present invention just provides the capsular preparation method of a kind of treatment hepatitis B disease.
The objective of the invention is to realize through following approach: according to the cause of disease and pathology, the selected tens of kinds of Chinese herbal medicine of suiting the medicine to the illness, the method for utilization blood circulation promoting and blood stasis dispelling, can hepatocyte newborn soon, liver protecting and nourishing, tonifying speen and tonifying kidney be treated B-mode inflammation and can be cured rapidly.
The treatment hepatitis B capsule for treating of scheme preparation in the employing, generally through two to three courses of treatment (three months is a course of treatment), cure rate reaches 100%.
Further specify the capsular concrete grammar of preparation treatment hepatitis B below:
One, raw material is formed:
Flos Carthami 30g, Radix Paeoniae Rubra 30g, Semen Raphani 45g, Fructus Atriplicis Sibiricae 45g, Concha Haliotidis 150g, Fructus Ligustri Lucidi 45g, Radix Curcumae 45g, Radix Angelicae Sinensis body 45, Radix Paeoniae Alba 45g, Radix Glycyrrhizae 60g, Cortex Eucommiae 45g, Rhizoma Atractylodis Macrocephalae 45g, Radix Dipsaci 45g, clever Carapax et Plastrum Testudinis 100g, Carapax Trionycis 150g, Fructus Lycii 150g, Herba Artemisiae Scopariae 100g, Radix Salviae Miltiorrhizae 50g, Herba Lycopi 45g, Herba Hedyotidis Diffusae 150g.
Two, preparation method: Fructus Lycii is separately with the oven dry of roasting railway carriage or compartment, can not water content: other medical material is put into the oven dry of roasting railway carriage or compartment simultaneously, can not water content, and pulverizer is ground into the end, use 120 mesh sieves, sieve back mixing encapsulated (0.1g * 100 bottle), disinfection by ultraviolet light packages spare then.
Instructions of taking: day clothes 3 times, the 6-8 grain/time, prohibit vinegar-pepper.

Claims (1)

1. capsule for the treatment of hepatitis B is characterized in that its raw material consists of:
Flos Carthami 30g, Radix Paeoniae Rubra 30g, Semen Raphani 45g, Fructus Atriplicis Sibiricae 45g, Concha Haliotidis 150g, Fructus Ligustri Lucidi 45g, Radix Curcumae 45g, Radix Angelicae Sinensis body 45g, Radix Paeoniae Alba 45g, Radix Glycyrrhizae 60g, Cortex Eucommiae 45g, Radix Dipsaci 45g, clever Carapax et Plastrum Testudinis 100g, Carapax Trionycis 150g, Fructus Lycii 150g, Herba Artemisiae Scopariae 100g, Radix Salviae Miltiorrhizae 50g, Herba Lycopi 45g, Herba Hedyotidis Diffusae 150g.
CN98125078A 1998-12-02 1998-12-02 Capsule for curing hepatitis B Expired - Fee Related CN1067271C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98125078A CN1067271C (en) 1998-12-02 1998-12-02 Capsule for curing hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98125078A CN1067271C (en) 1998-12-02 1998-12-02 Capsule for curing hepatitis B

Publications (2)

Publication Number Publication Date
CN1227752A CN1227752A (en) 1999-09-08
CN1067271C true CN1067271C (en) 2001-06-20

Family

ID=5229009

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98125078A Expired - Fee Related CN1067271C (en) 1998-12-02 1998-12-02 Capsule for curing hepatitis B

Country Status (1)

Country Link
CN (1) CN1067271C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1321675C (en) * 2000-11-24 2007-06-20 张志祥 Liver-spleen capsule and its preparing process
CN100528218C (en) * 2003-12-30 2009-08-19 乡城县藏医院 Pharmaceutical composition, its preparation process and usage
CN103735650A (en) * 2013-12-30 2014-04-23 杨昌富 Chinese herb preparation for treating infectious canine hepatitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
新中医 1994,26(10) 1994.1.1 唐光钰 乙肝抵抗丸治疗慢性乙性肝炎42例 *

Also Published As

Publication number Publication date
CN1227752A (en) 1999-09-08

Similar Documents

Publication Publication Date Title
CN101879298B (en) Chinese patient medicament for treating cardiovascular and cerebrovascular diseases
CN100496586C (en) Medicinal liquor for treating hyperosteogency and koilorrhachic
CN1298346C (en) Dynamic medicine for channels and collaterals and blood vessel
CN101161273B (en) A Chinese patent medicine for treating catagmat
CN1062157C (en) Hepatitis B curing toxin-dissipating pill
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN101366892A (en) Chinese medicinal composition for treating menorrhalgia
CN1421234A (en) Oral liquid for treating hepatitis B
CN1278446A (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN1772092A (en) Chinese medicine for treating kidney deficiency caused sterility
CN1174737A (en) Pill for type of tubercular disease found in women, usu. characterized by menoustasis recurent low fever and general degility.
CN1178689C (en) Process for preparing Chinese medicine as skin lotion
CN1332702C (en) Medicine for treating psoriasis
CN1201691A (en) Medicine for curing encephalatrophy and preparation thereof
CN1067271C (en) Capsule for curing hepatitis B
CN1201757C (en) Boneset pills
CN1140291C (en) Stone-eliminating Jinyin medicine powder
CN1557354A (en) Chinese medicine aqueous pill preparation for treating hepatitis B and its preparation process
CN1175441A (en) Medicine for releasing wind-heat toxin in blood
CN101926880A (en) Chinese medicinal composition for treating amenorrhea and endometritis of women
CN1070378C (en) Medicine for curing hepatitis B
CN1428164A (en) Thrombosis-eliminating collaterals-activating capsule
CN102302666A (en) Health care medicinal liquor
CN102058813B (en) Health protection pill for nourishing kidney and spleen and preventing yang deficiency and preparation method thereof
CN1078476C (en) Gastric cancer treating Chinese medicine preparation

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Zeng Qingxiang

Document name: payment instructions

C19 Lapse of patent right due to non-payment of the annual fee
C57 Notification of unclear or unknown address
CF01 Termination of patent right due to non-payment of annual fee
DD01 Delivery of document by public notice

Addressee: Zeng Qingxiang

Document name: Notification of Termination of Patent Right